Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas

INTRODUCTION: More than 90% of patients with pancreatic cancer present either with incurable locally advanced or metastatic disease or relapse following surgery. For these patients systemic therapy offers the only prospect of salvage, but pancreatic cancer is one of the most chemoresistant of tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, David B., Neoptolemos, John P.
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Outcomes Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012429/
https://www.ncbi.nlm.nih.gov/pubmed/21221179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012429/
https://www.ncbi.nlm.nih.gov/pubmed/21221179

Ejemplares similares